PLEASANTON, Calif,, Feb. 22, 2022 /PRNewswire/ -- 10x Genomics, Inc. (NASDAQ:TXG), a life sciences leader focused on mastering biology to advance human health, today unveiled new details about ...

Products/Pipeline. 10x Genomics offers a variety of applications and products for customers to analyze biological systems at fundamental resolutions on massive scales. 10x's offerings cover three ...

10x Genomics, Inc. (Nasdaq: TXG), a leader in single cell and spatial biology, today announced the launch of Chromium Xo, ... With Chromium Xo and what's planned in our pipeline, ...

Portfolio and Pipeline. 10x Genomics has a line of consumables for their chromium instruments, as well as associated software.

10x Genomics Unveils Innovation Roadmap at AGBT General Meeting, Advancing Leadership in Large-Scale Single Cell and Spatial Analysis. Published 8:30 am Sunday, February 23, 2025 ...

10X Genomics, Inc. is a life science technology company, which engages in building products to interrogate, understand and master biology. Its integrated ...

10x Genomics employed 584 workers worldwide at the end of 2019, 852 people at the end of 2020, 1,239 people at the end of 2021 and 1,243 at the end of 2022, the SEC filings showed.

Genomics company 10x and Harvard University have agreed to resolve a patent lawsuit against 10x's rival Vizgen four days into a scheduled two-week trial, according to a Thursday filing in Delaware ...

Genomics startup Parse Biosciences lost its bid to dismiss a patent-infringement lawsuit brought by rival 10x Genomics and Stanford University on Thursday, when a Delaware federal court denied ...

PLEASANTON, Calif., Sept. 3, 2024 /PRNewswire/ --10x Genomics, Inc. (Nasdaq: TXG ), a leader in single cell and spatial biology, today annou Tuesday, 02 January 2024 12:17 GMT عربي ...